Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis

EuroIntervention

Volumn 5, Issue 4, 2009, Pages 454-459

  Liistro, Francesco ^a   Fineschi, Massimo ^b   Grotti, Simone ^a   Angioli, Paolo ^a   Carrera, Arcangelo ^b   Ducci, Kenneth ^a   Gori, Tommaso ^b   Falsini, Giovanni ^a   Pierli, Carlo ^b   Bolognese, Leonardo ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Clinical outcome; Drug eluting stent restenosis; Late thrombosis; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE; HEPARIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAROTID ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC DRIVEN TARGET LESION REVASCULARIZATION; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; REGISTER; REOPERATION; REVASCULARIZATION; TREATMENT PLANNING; CORONARY BLOOD VESSEL; DISEASE FREE SURVIVAL; IMPLANTATION; ITALY; LENGTH OF STAY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RESTENOSIS; SURVIVAL; SURVIVOR; TIME; VASODILATATION;

AGED; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; ITALY; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS IMPLANTATION; REGISTRIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; VASODILATION;

EID: 77950461935     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV5I4A72     Document Type: Article

References (21)

1. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989-97. (Pubitemid 46376799)
2. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030-9. (Pubitemid 46376803)
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008. (Pubitemid 46376800)
4. Daemen J, Garcia-Garcia HM, Kukreja N, Imani F, de Jaegere PP, Sianos G, van Domburg RT, Serruys PW. The long-term value of sirolimusand paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J. 2007;28:26-32. (Pubitemid 46134954)
5. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663-70. (Pubitemid 41175674)
6. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1172-9. (Pubitemid 40523133)
7. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004;109:2273-8. (Pubitemid 38678518)
8. Colombo A. Contemporary treatment of coronary bifurcations with drug-eluting stent: part II. J Interv Cardiol. 2006;19:51-3.
9. Migliorini A, Moschi G, Vergara R, Parodi G, Carrabba N, Antoniucci D. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv. 2006;67:344-8. (Pubitemid 43346730)
10. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol. 2004;44:2301-6. (Pubitemid 39647602)
11. Werner GS, Schwarz G, Prochnau D, Fritzenwanger M, Krack A, Betge S, Figulla HR. Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents. Catheter Cardiovasc Interv. 2006;67:1-9. (Pubitemid 43062598)
12. Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Babic R, Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M, Colombo A. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent. Am Heart J. 2007;153:354-9. (Pubitemid 46328767)
13. Mishkel GJ, Moore AL, Markwell S, Shelton MC, Shelton ME. Longterm outcomes after management of restenosis or thrombosis of drugeluting stents. J Am Coll Cardiol. 2007;49:181-4. (Pubitemid 46054395)
14. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of instent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-8. (Pubitemid 29511140)
15. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-9. (Pubitemid 46376802)
16. Torguson R, Sabate M, Deible R, Smith K, Chu WW, Kent KM, Pichard AD, Suddath WO, Satler LF, Waksman R. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis. Am J Cardiol. 2006;98:1340-4. (Pubitemid 44666639)
17. Costa MA. Treatment of drug-eluting stent restenosis. Am Heart J. 2007;153:447-9. (Pubitemid 46440702)
18. Liistro F, Fineschi M, Angioli P, Sinicropi G, Falsini G, Gori T, Ducci K, Bravi A, Bolognese L. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol. 2006;48:270-5.
19. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995-8. (Pubitemid 40432428)
20. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051-8. (Pubitemid 46328299)
21. Blackman DJ, Porto I, Shirodaria C, Channon KM, Banning AP. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol. 2004;94:922-5. (Pubitemid 39349558)